Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Revenue: 2021-2024

Historic Revenue for Addex Therapeutics (ADXN) over the last 4 years, with Dec 2024 value amounting to $459,343.

  • Addex Therapeutics' Revenue fell 42.06% to $73,860 in Q2 2025 from the same period last year, while for Jun 2025 it was -$34.2 million, marking a year-over-year decrease of 3738.19%. This contributed to the annual value of $459,343 for FY2024, which is 74.42% down from last year.
  • Addex Therapeutics' Revenue amounted to $459,343 in FY2024, which was down 74.42% from $1.8 million recorded in FY2023.
  • Over the past 5 years, Addex Therapeutics' Revenue peaked at $1.8 million during FY2023, and registered a low of -$34,526 during FY2021.
  • Its 3-year average for Revenue is $1.2 million, with a median of $1.5 million in 2022.
  • In the last 5 years, Addex Therapeutics' Revenue surged by 4,418.88% in 2022 and then crashed by 74.42% in 2024.
  • Yearly analysis of 4 years shows Addex Therapeutics' Revenue stood at -$34,526 in 2021, then soared by 4,418.88% to $1.5 million in 2022, then increased by 20.44% to $1.8 million in 2023, then tumbled by 74.42% to $459,343 in 2024.